Accuracy of several cervical screening strategies for early detection of cervical cancer: A meta-analysis

International Journal of Gynecological Cancer

Volumn 22, Issue 6, 2012, Pages 908-921

  Chen, Changxian ^a   Yang, Zhijun ^a   Li, Zhuang ^a   Li, Li ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer screening; Cytology; HPV testing; Meta analysis; Visual inspection

Indexed keywords

ACETIC ACID; LUGOL;

CANCER SCREENING; CELL HETEROGENEITY; COCHRANE LIBRARY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; EMBASE; HUMAN; HYBRID CAPTURE 2 ASSAY; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ACETIC ACID; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLORING AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IODIDES; MASS SCREENING; PAPILLOMAVIRIDAE; REGRESSION ANALYSIS; ROC CURVE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84863622818     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318256e5e4     Document Type: Review

References (67)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Parkin DM, Almonte M, Bruni L, et al. Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine. 2008;26:L1YL15.
3. Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide. Asian Pac J Cancer Prev. 2009;10: 645-650.
4. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer. 2000;86:429-435.
5. Comprehensive Cervical Cancer Control: A Guide to Essential Pratice. Switzerland: World Health Organization; 2006.
6. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370:398-406.
7. Sherris J, Wittet S, Kleine A, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health. 2009;35:147-154.
8. Payne N, Chilcott J, McGoogan E. Liquid-based cytology in cervical screening: a rapid and systematic review. Health Technol Assess. 2000;4:1-73.
9. Arbyn M, Buntinx F, Van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intra-epithelial neoplasia. J Natl Cancer Inst. 2004;18;96: 280-293.
10. Karnon J, Peters J, Platt J, et al. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess. 2004;8:iii, 1-78.
11. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101.
12. Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111:167-177.
13. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123:153-160.
14. Sritipsukho P, Thaweekul Y. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. J Med Assoc Thai. 2010;93:S254YS261.
15. Sauvaget C, Fayette JM, Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynecol Obstet. 2011;113:14-24.
16. Koliopoulos G, Arbyn M, Martin-Hirsch P, et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol. 2007;104: 232-246.
17. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess. 1999;3:iii, 130.
18. Rebolj M, Bonde J, Njor SH, et al. Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ. 2011;342:2757.
19. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
20. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7-18.
21. Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
22. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12:1293-1316.
23. Song F, Sheldon TA, Sutton AJ, et al. Methods for exploring heterogeneity in meta-analysis. Eval Health Prof. 2001;24:126-151.
24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
25. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2:9.
26. Zhao FH, Zhang WH, Pan QJ, et al. A study of cervical cancer screening algorithms [in Chinese]. Zhonghua zhong liu za zhi [Chin J Oncol]. 2010;32:420-424.
27. Pretorius RG, Kim RJ, Belinson JL, et al. Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy. J Low Genit Tract Dis. 2006;10:5-9.
28. Wu LY, Li N, Zhang WH, et al. Value of acetic acid smear test for cervical cancer screening [in Chinese]. Ai Zheng. 2003;22:1096-1098.
29. Pan Q, Belinson JL, Li L, et al. A thin-layer, liquid-based Pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta Cytol. 2003;47:45-50.
30. Belinson JL, Pan QJ, Biscotti C, et al. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol. 2002;46:470-474.
31. Pan Q, Li L, Qiao Y. Comparative study on liquid-based cytology for cervical carcinoma screening in a high-risk area of China [in Chinese]. Zhonghua Zhong Liu Za Zhi. 2001;23:309-312.
32. Belinson JL, Pretorius RG, Zhang WH, et al. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol. 2001;98:441-444.
33. Fei HL, Cheng YF, Cheng XD, et al. Evaluation of five screening methods for an early detection of cervical cancer and its precancerous lesions in Zhejiang province [in Chinese]. Zhonghua Yi Xue Za Zhi. 2011;91:309-312.
34. Wu S, Meng L, Wang S, et al. A comparison of four screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;91:189-193.
35. Rodriguez-Reyes ER, Cerda-Flores RM, Quinonez-Perez JM, et al. Acetic acid test: a promising screening test for early detection of cervical cancer. Anal Quant Cytol Histol. 2002;24:134-136.
36. Blumenthal PD, Gaffikin L, Chirenje ZM, et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynecol Obstet. 2001;72:47-53.
37. Ngelangel CA, Limson GM, Cordero CP, et al. Acetic-acid guided visual inspection vs. cytology-based screening for cervical cancer in the Philippines. Int J Gynecol Obstet. 2003;83:141-150.
38. Sankaranarayanan R, Shastri SS, Basu P, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev. 2004;28:345-351.
39. Sankaranarayanan R, Basu P, Wesley RS, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110:907-913.
40. Sankaranarayanan R, Chatterji R, Shastri SS, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer. 2004;112:341-347.
41. Shastri SS, Dinshaw K, Amin G, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005;83:186-194.
42. Ngoma T, Muwonge R, Mwaiselage J, et al. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynecol Obstet. 2010;109:100-104.
43. Muwonge R, Manuel MDG, Filipe AP, et al. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynecol Obstet. 2010;111:68-72.
44. Murillo R, Luna J, Gamboa O, et al. Cervical cancer screening with naked-eyevisual inspection inColombia. Int J GynecolObstet. 2010;109:230-234.
45. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929-936.
46. Sankaranarayanan R, Thara S, Sharma A, et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen. 2004;11:77-84.
47. Sankaranarayanan R, Wesley R, Thara S, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106:404-408.
48. Garcia F, Barker B, Santos C, et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol. 2003;102:266-272.
49. Basu PS, Sankaranarayanan R, Mandal R, et al. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer. 2003;13:626-632.
50. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001;83:439-444.
51. Costa S, Sideri M, Syrjanen K, et al. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol. 2000;44: 310-318.
52. Gaffikin L, Blumenthal PD, McGrath J, et al. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet. 1999;353:869-873.
53. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79:954-962.
54. Anderson GH, Boyes DA, Benedet JL, et al. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. Br Med J (Clin Res Ed). 1988;296:975-978.
55. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987;1:1247-1249.
56. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol. 1985;29:1043-1046.
57. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737-743.
58. Bosch MM, Rietveld-Scheffers PE, Boon ME. Characteristics of false-negative smears tested in the normal screening situation. Acta Cytol. 1992;36:711-716.
59. Agency for Healthcare Research and Quality. Evaluation of Cervical Cytology: Evidence Report/Technology Assessment (no. 5). Rockville, MD: AHCPR; 1999. Online monograph. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK32961/.
60. Guidos BJ, Selvaggi SM. Use of the ThinPrep Pap test in clinical practice. Diagn Cytopathol. 1999;20:70-73.
61. Blumenthal PD, Lauterbach M, Sellors JW, et al. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005;89:S30YS37.
62. Tsu VD, Pollack AE. Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold? Int J Gynaecol Obstet. 2005;89:S55YS59.
63. Aggarwal P, Batra S, Gandhi G, et al. Comparison of Papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings. Int J Gynecol Cancer. 2010;20:862-868.
64. Winkler JL, Lewis K, Del Aguila R, et al. Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru. Rev Panam Salud Publica. 2008;23:1-6.
65. Sodhani P, Gupta S, Sharma JK, et al. Test characteristics of various screening modalities for cervical cancer: a feasibility study to develop an alternative strategy for resource-limited settings. Cytopathology. 2006;17:348-352.
66. Rodriguez AC, Morera LA, Bratti C, et al. Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population. J Low Genit Tract Dis. 2004;8:132-138.
67. Al Khalaf MM, Thalib L, Doi SA. Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses. J Clin Epidemiol. 2011;64: 119-123.